SOPHARMA AD: Treasury shares

opublikowano: 2018-12-04 13:49

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_138_buy_back_04122018_espi.pdf  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 138 / 2018
Date of issue: 2018-12-04
Short name of the issuer
SOPHARMA AD
Subject
Treasury shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on December 4, 2018 as a result of the distribution of bonus shares to employees on the occasion of the 85th Anniversary of Sopharma AD, the Company transferred to its employees 100 own shares representing 0.0001% of the capital of the Company.
The total number of treasury shares after this transfer is 8 837 266, representing 6.56% of the share capital of the Company.
Annexes
File Description
Current report 138 buy back 04122018 espi.pdfCurrent report 138 buy back 04122018 espi.pdf Treasury shares

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2018-12-04 Ognian Donev Executive director